LUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares

Bulletin Express

Mar 04

Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.

The announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1163719670"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1163719670\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1163719670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 17:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163719670","market":"hk","top_or_hot":-1,"title":"LUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares","media":"Bulletin Express","content":"<p>Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.</p>\n<p>The announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-04 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.</p>\n<p>The announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02480","symbol_name":"绿竹生物-B","start_time":0,"source_url":"","article_id":"1163719670","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163719670","pubTimestamp":1772615698,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02480":"绿竹生物-B"},"translate_title":"露珠生物-B(02480)公布2026年2月已发行股份无变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02480":1},"content_text":"Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.\nThe announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}